-
A Treatment That Came Just in Time
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
-
More Data on COVID-19 Vaccination and Cancer
Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.
by Anna Goshua
-
Building COVID-19 Vaccine Confidence
Experts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population.
by Kevin McLaughlin
-
Searching the Blood for Signs of Altered Immunity
The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.
by Kate Yandell
-
A Drive for Diversity
African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.
by Jon Kelvey
-
Cancer and COVID-19 Vaccination
Amid continued research showing the impact of COVID-19 on people with cancer, patients are asking when they should get a COVID-19 vaccine.
by Marci A. Landsmann
-
Despite Generic Imatinib, Cost of Treating CML Remains High
The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.
by Anna Azvolinsky
Cancer Talk
Researchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. Landsmann
AACR Annual Meeting 2023Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.
More Prostate Cancer Patients Choose SurveillanceMen are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose
Childhood Cancer Survivors Face Higher Mortality for DecadesAn increased risk of early death exists even after treatment for childhood cancer, but survivors also have the potential for decades of life after cancer.
by Sandra Gordon
From the AACR
-
The Many Aspects of Early Detection and Interception of Cancer
Early detection is key to improving outcomes from cancer. Research in cancer interception aims to characterize tumors at the earliest stages of development.
-
Translating Personal Tragedy Into the Search for New Cancer Therapeutics
Dr. Patricia LoRusso’s parents both died of cancer when she was a teenager, inspiring her to become an oncologist and develop new treatments for people with cancer.
Video
Bringing Cancer Research to Life: Elizabeth M. Jaffee, MD, FAACR
